Publication | Open Access
Evaluating Haemodynamic Changes: Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction
16
Citations
12
References
2024
Year
The consistent reduction in PAWP underscores the well-tolerated nature of vericiguat and its potential to enhance cardiac performance in patients with HFrEF.
| Year | Citations | |
|---|---|---|
Page 1
Page 1